Why invest in EZZ Life Science Holdings

The Company is the exclusive wholesale distributor for the EAORON branded skin care range to pharmacies, supermarkets and specialist retailers in Australia and New Zealand and owns, produces, designs and distributes its own range of consumer health products under the EZZ brand.

The Company is led by an experienced senior management team that has implemented strategies to drive rapid and ongoing growth of the business. The Board’s Audit and Risk Committee will be closely managing the risks to ensure practical and responsive mitigation programs are implemented and multi-jurisdictional growth is managed accordingly.

The Company has two distinct and synergistic business models:

a wholesale distribution model for the EAORON branded products in the skin care segment; and
an integrated model including development, production and distribution for the EZZ branded products in the consumer health segment.

Synergy is created by selling the EZZ branded products to established distribution channels previously developed from selling the EAORON branded products.

ASX ANNOUNCEMENTS

EZZ to be added to MSCI World Micro Cap Index

November 11, 2024

Appendix 3A.1 – Notification of Dividend Distribution

October 28, 2024

Final Dividend Announcement

October 28, 2024

View All ASX Announcement

IN THE NEWS

EZZ makes hair easy

July 15, 2024

EZZ products to gain exposure to increasing Chinese tourist numbers at Auckland airport under duty-free deal

March 26, 2024

Aussie Brands ‘Speed Dating’ And Live Streaming To Success With Alibaba

March 26, 2024

View All News

EMAIL ALERTS

Subscribe now for your company latest news.

PROSPECTUS

View Our Prospectus Here

DISCLAIMER

Important Information

You must read this important notice before you attempt to access the electronic version of the Prospectus through this website. The information on this page is not part of the Prospectus. If you do not understand it, you should consult your professional adviser without delay.

Lodgement of Prospectus with ASIC

This Prospectus has been lodged with the Australian Securities and Investments Commission. An application for securities can be made by completing the Application Form attached to or accompanied by the Prospectus and then lodging the form and the application monies in accordance with the details set out in the Prospectus and the Application Form.

No Advice

Nothing contained on this website or in the Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of the Company and the securities and terms of the offering, including the merits and risks involved. You should consult your professional adviser for legal, business or tax advice.

Warning

For legal reasons, the electronic version of the Prospectus accessible through this website is available to persons accessing this website from within Australia, New Zealand and the United Kingdom only. If you are accessing this website from anywhere outside Australia, New Zealand and the United Kingdom, please do not download the electronic version of the Prospectus. The Prospectus does not constitute an offer of securities in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus or make the offer. It is the responsibility of any applicant outside Australia, New Zealand and the United Kingdom to ensure compliance with all laws of any country relevant to their applications, and any such applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be allotted any securities. It is not practicable for the Company to comply generally with the securities laws of overseas jurisdictions having regard to the number of overseas shareholders, the number and value of securities these shareholders would be offered and the cost of complying with regulatory requirements in each relevant jurisdiction. Accordingly, the offer pursuant to the Prospectus is only being extended and securities will only be issued to shareholders with a registered address in Australia, New Zealand and the United Kingdom. By proceeding, you acknowledge and agree to the above statements.

FormCraft - WordPress form builder

INVESTOR SERVICES

View our current investor services here.